FDA 483 OBSERVATION · #1291 OF 1,932 MOST-CITED

Records of continuing review

FDA cited this observation 11 times across 11 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Bioresearch Monitoring11
BY FISCAL YEAR
FY20231
FY20222
FY20211
FY20201
FY20181
FY20171
FY20164

How FDA worded it — real examples

Records have not been prepared of all continuing review activities.

AtlantiCare Regional Medical Center IRB · Atlantic City, New Jersey · Bioresearch Monitoring · 2023-02-10

Records have not been prepared and maintained of all continuing review activities.

Larkin Community Hospital IRB · South Miami, Florida · Bioresearch Monitoring · 2021-11-19

Records have not been prepared and maintained of all continuing review activities.

Institute of Regenerative and Cellular Medicine · Santa Monica, California · Bioresearch Monitoring · 2021-10-19

Records have not been prepared of all continuing review activities.

Milind Javle, MD · Houston, Texas · Bioresearch Monitoring · 2020-12-21

Records have not been prepared of all continuing review activities.

Naval Medical Center San Diego IRB · San Diego, California · Bioresearch Monitoring · 2019-11-20

Records have not been prepared and maintained of all continuing review activities.

Montana State University- Bozeman IRB · Bozeman, Montana · Bioresearch Monitoring · 2018-08-02

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

GCP discipline →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →